H02.SI

Haw Par Corporation Limited [H02.SI] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

H02.SI Stock Summary

Top 10 Correlated ETFs

H02.SI

Top 10 Correlated Stocks

H02.SI

In the News

H02.SI Financial details

Company Rating
-
Market Cap
2.17B
Income
364.89M
Revenue
414.15M
Book val./share
-
Cash/share
-
Dividend
0.35
Dividend %
3.61%
Employees
-
Optionable
No
Shortable
Yes
Earnings
23 Feb 2024
P/E
12.27
Forward P/E
-
PEG
0.84
P/S
10.86
P/B
0.63
P/C
-
P/FCF
92.58
Quick Ratio
35.77
Current Ratio
36.54
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.65
EPS next Y
-
EPS next Q
-
EPS this Y
46.27%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
3.63%
Revenue last 5Y
-1%
Revenue Q/Q
8.83%
EPS Q/Q
8.51%
-
-
-
-
SMA20
3.3%
SMA50
-3.63%
SMA100
5.9%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
7%
ROC
0.01%
Gross Margin
55%
Oper. Margin
26%
Profit Margin
89%
Payout
38%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.11-10.22
52W High
+26.5%
52W Low
+40.56%
RSI
69.22
Rel Volume
0.9
Avg Volume
71.24K
Volume
63.8K
Perf Week
6.75%
Perf Month
7.2%
Perf Quarter
12.15%
Perf Half Y
13.35%
-
-
-
-
Beta
0.409
-
-
Volatility
0.39%, 0.3%
Prev Close
-0.39%
Price
12.65
Change
-1.33%

H02.SI Financial Performance

H02.SI Dividend History

H02.SI Frequently Asked Questions

What is Haw Par Corporation Limited stock symbol ?

Haw Par Corporation Limited is a SG stock and trading under the symbol H02.SI

What is Haw Par Corporation Limited stock quote today ?

Haw Par Corporation Limited stock price is $12.65 today.

Is Haw Par Corporation Limited stock public?

Yes, Haw Par Corporation Limited is a publicly traded company.

Something similar

Top by Market Cap
BRYN.DE
NVDA
DHR-PB
NVD.DE
ABEC.DE
Top Correlated ETFs
LUXU.L
LUXG.L
CAPU.L
5HED.L
LUXU.PA
Top Correlated Stocks
GABRIEL.NS
7965.T
AKSHARCHEM.NS
5938.T
5951.T
Similar Market Cap
IDL.PA
SKYY
DMIDX
603808.SS
SBMO.AS

Company Profile

Healthcare Drug Manufacturers - General
  • Volume Average 71.24K
  • Market Capitalization 2.17B
  • CEO Mr. Ee Lim Wee
  • Headquarters Singapore,SG
  • IPO Date 2000-01-03
  • Website https://www.hawpar.com

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. The Healthcare segment principally manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brand. Its Investments segment invests primarily in quoted securities. In addition, the company owns and leases various investment properties that have lettable area of 45,324 square meters of commercial and industrial space in Singapore and Malaysia. Further, the company provides family and tourist oriented leisure alternatives principally in the form of oceanariums. Haw Par Corporation Limited leases land, building, and office space, as well as offers management support services. The company was incorporated in 1969 and is based in Singapore.